Mach7 Technologies share price is up 5% on first full year profit result

The Mach7 Technologies share price has surged after the company delivered its first full year profit result and a positive cash flow.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Mach7 Technologies Ltd (ASX: M7T) share price is up almost 5% higher today after delivering its first full year profit result.

The company develops innovative enterprise imaging and informatics solutions for image viewing, storage, and workflow management. 

What were the FY20 results?

The company has delivered an increase in revenues of $18.9 million, up 102% on the prior corresponding period (pcp). This was driven mainly by higher software licence fees. 

Earnings before interest, taxation, depreciation and amortisation (EBITDA) was $3.3 million, up 181% compared to the pcp. 

Mach7 delivered positive free cash flow, up 225% to $4.7 million. The company said the acquisition of Client Outlook demonstrated the scalability of the business and enabled less reliance on investor funding.

The company's successful completion of a cost-reduction program was a key contributor to profit.

Sales orders were up 115% as a result of 29 new sales order contracts. These were from new and existing customers who ordered licence extensions, expansion licences or new products.  The 29 orders have contributed $13.3 million to the group's revenues.

Furthermore, contracted annual recurring revenue (CARR) has increased to $9 million, representing growth of 14% on the pcp. However, CARR growth was impacted by delayed purchasing decisions in 2H20 due to the coronavirus pandemic.

Outlook for Mach7

Mach7 Technologies expects the growth in CARR to resume and even accelerate during the 2H21 due to expected increased demand. This is reflected in the sales pipeline. 

In light of the Client Outlook purchase, the company is well-positioned for continued profit growth in a substantially larger addressable market. It's now a clear market leader in the provision of complete enterprise imaging solutions. 

Mach7 Technologies is in a strong financial position with more than $15 million cash in the bank and is debt free. In the future, it expects to deliver continued double-digit revenue growth, EBITDA growth and positive free cash flows. 

Mach7 CEO Mike Lampron said Mach7 was well-positioned to continue delivering great outcomes for customers, employees and investors.

"I am proud of what the Mach7 team has achieved this year – from new customer deployments of our software, the recent acquisition and early integration of Client Outlook, to delivery of proftable high growth earnings and positive free cash flow," he said.

After surging to a high of $1.15 in early afternoon trade today, the Mach7 Technologies share price is currently trading at $1.10, up 4.76% at the time of writing. It has a market capitalisation of $263.7 million.

Matthew Donald has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and recommends MACH7 FPO. The Motley Fool Australia has recommended MACH7 FPO. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A bored man sits at his desk, flat after seeing the latest news on the share market.
Real Estate Shares

REA shares fall 43% to a three-year low. Is it time to buy?

REA Group shares have fallen even further into the red on Tuesday morning.

Read more »

A man in a supermarket strikes an unlikely pose while pushing a trolley, lifting both legs sideways off the ground and looking mildly rattled with a wide-mouthed expression.
Consumer Staples & Discretionary Shares

Woolworths shares soar to new multi-year high: Buy, sell or hold?

After a bumpy start to the year, the supermarket giant's shares are back in favour with investors.

Read more »

A panel of four judges hold up cards all showing the perfect score of ten out of ten
Opinions

I'd buy this ASX share because it offers almost everything an investor could want

This business ticks a lot of boxes!

Read more »

A young man punches the air in delight as he reacts to great news on his mobile phone.
Broker Notes

Up 293%! Can Electro Optic Systems (EOS) shares keep rising?

Bell Potter believes this high-flying stock hasn't peaked yet.

Read more »

Two hikers high five each other having climbed to the top pinnacle of the mountain.
Share Gainers

Up 1,700% and more, what's next for these ASX 200 shares?

The market's biggest winners face their next test.

Read more »

Five healthcare workers standing together and smiling.
Broker Notes

Up 21% since November, should I buy this dividend paying ASX All Ords healthcare share today?

A leading expert tips one ASX All Ords share to buy and one to sell today.

Read more »

Two university students in the library, one in a wheelchair, log in for the first time with the help of a lecturer.
Share Market News

5 things to watch on the ASX 200 on Tuesday

A better day is expected for Aussie investors today.

Read more »

Time to sell written on a clock.
Broker Notes

3 reasons why experts think CSL shares are a sell

Earnings pressure and downgrades weigh heavily on the biotech stock.

Read more »